Recital 8, Regulation (EU) 2019/88

In forcesince 18 Jan 2019

In accordance with Article 43 of Regulation (EC) No 396/2005, the Commission requested the Authority to assess the risks the current MRLs for acetamiprid may pose to consumers in the light of the resulting lower acute reference dose (ARfD).